Essential readings:
Verma A, St Clair EW, Radtke RA. A case of sustained massive gabapentin overdose without serious side effects. Therapeutic Drug Monitoring. 1999;21(6):615-617.
Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clinical therapeutics. 2004;26(4):552-561.
Passik S.D, Casper D, Kirsh K.L. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain medicine. 2008;9(Suppl. 2):166.
Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction. 2010;105(4):601-614.
Geneste J, Pereira B, Arnaud B, Christol N, Liotier J, Blanc O, et al. CAGE, RAPS4, RAPS4-QF and AUDIT screening tests for men and women admitted for acute alcohol intoxication to an emergency department: are standard thresholds appropriate? Alcohol and Alcoholism. 2012 May-Jun;47(3):273-81.
Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B. Characterization of gabapentin overdose using a poison center case series. Journal of Toxicology Clinical Toxicology. 2003;41(1):11-15.
Dangerous addiction – should doctors be tested for drug use? The Conversation, May 25, 2012.
Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. Journal of Pain and Symptom Management. 2004;27(5):440-459.
Marshall EJ. Doctors’ health and fitness to practise: treating addicted doctors. Occupational Medicine, 2008;58(5):334–340.
Robinson G. Doctors’ poor health – still an issue? Newsletter of the Medical Council of New Zealand, 2008;(46):7-8. [web archive]
NSW Ministry of Health. 2008. Drug and Alcohol Withdrawal Clinical Practice Guidelines - NSW.
Rubinsky AD, Kivlahan DR, Volk RJ, Maynard C, Bradley KA. Estimating risk of alcohol dependence using alcohol screening scores. Drug and alcohol dependence. 2010;108(1-2):29-36.
Ballantyne JC, Fleisher LA. Ethical issues in opioid prescribing for chronic pain. Pain. 2010;148(3):365-367.
Rich BA. 2007. Ethics of Opioid Analgesia for Chronic Noncancer Pain. Pain: Clinical Updates, 2007;15(9).
Schauer SG, Varney SM. Gabapentin overdose in a military beneficiary. Military Medicine. 2013;178(1):133-135.
Lewis SS, Hutchinson MR, Zhang Y, et al. Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain. Brain behavior and immunity. 2013;30:24-32.
Haber P, Australia. Department of Health and Ageing. Guidelines for the Treatment of Alcohol Problems. Canberra: Dept. of Health and Ageing; 2009.
Lee K, Freeburn B, Ella S, Miller W, Perry J, Conigrave K. 2012. Handbook for Aboriginal Alcohol and Drug Work. The University of Sydney, Discipline of Addiction Medicine, Sydney Medical School.
Medical Council of New Zealand. 2014. Health Practitioners Competence Assurance Act (HPCAA) webpage.
Teasdale KE, Conigrave KM, Kiel KA, Freeburn B, Long G, Becker K. Improving services for prevention and treatment of substance misuse for aboriginal communities in a sydney area health service. Drug and Alcohol Review. 2008;27(2):152-159.
Gunja N. In the zzz zone: the effects of z-drugs on human performance and driving. Journal of Medical Toxicology. 2013;9(2):163-171.
Brötz D, Maschke E, Burkard S, et al. Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica? Pain. 2010;149(3):470-475.
Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American pain society and American academy of pain medicine clinical practice guideline. The Journal of Pain : Official Journal of the American Pain Society.
Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. The Clinical Journal of Pain. 2006;22(2):173-181.
Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. The Clinical Journal of Pain. 1997;13(2):150-155.
Rosen A, Wilson A, Randal P, et al. Psychiatrically impaired medical practitioners: better care to reduce harm and life impact, with special reference to impaired psychiatrists. Australasian Psychiatry : Bulletin of Royal Australian and New zealand College of Psychiatrists. 2009;17(1):11-18.
Haber P, Lintzeris N, Proude E, Lopatko O. 2009. Quick reference guide to the treatment of alcohol problems: companion document to the guidelines for the treatment of alcohol problems. Australian Government Commonwealth Department of Health and Ageing.
Doctors' health and wellbeing. ANZCA.
Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use:evaluation of a pilot assessment tool. Journal of Pain and Symptom Management. 1998;16(6):355-363.
Belgrade MJ, Schamber CD, Lindgren BR. The dire score: predicting outcomes of opioid prescribing for chronic pain. Journal of Pain. 2006;7(9):671-681.
World Health Organization (WHO), Carter A, Hall W. 2007. The ethical use of psychosocially assisted pharmacological treatments for opioid dependence.
Australian Health Practitioner Regulation Agency. 2014. The National Law mandatory notifications webpage.
Tōmaiora Māori Health Research Group. Tōmaiora Māori health research group website.
Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Medicine. 2005;6(2):107-112.
コメント